pulmonary-hypertension

Documents about pulmonary-hypertension

• Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients#448170ClinicalTrials.gov
• Impact of Pulmonary Endarterectomy on Sleep-Related Breathing Disorders in CTEPH: The IPES Trial#877638ClinicalTrials.gov
• Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation#968221ClinicalTrials.gov
• Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure#993278ClinicalTrials.gov
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.#1030220ClinicalTrials.gov
• Gut microbiota crosstalk mechanisms are key in pulmonary hypertension : the involvement of melatonin is instrumental too#248620SUNScholar
• Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension#383641ClinicalTrials.gov
• Burden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023#784393Europe PMC
• Measurement of Endothelial Function and Cardiac Output: New Methods#872533ClinicalTrials.gov
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment#851552ClinicalTrials.gov
• Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension#891277ClinicalTrials.gov
• Data Sheet 1_Patterns of right ventricular reverse remodeling and hemodynamic drivers in serial balloon pulmonary angioplasty.docx#202139Figshare
• Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH#390989ClinicalTrials.gov
• First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects#474841ClinicalTrials.gov
• Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty#830487ClinicalTrials.gov
• Maternal Cardiovascular Outcomes in Pregnancies Complicated by Pulmonary Hypertension: A Multicenter Cohort Study#215009DigitalCommons@WayneState
• Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)#471541ClinicalTrials.gov
• Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH#28488ClinicalTrials.gov
• Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor#136170ClinicalTrials.gov
• Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During Exercise#180276ClinicalTrials.gov
• L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension#189437ClinicalTrials.gov
• Steroid-Responsiveness in TBX4-Associated Pulmonary Hypertension and Interstitial Lung Disease#200185bioRxiv / medRxiv
• Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia#230553ClinicalTrials.gov
• Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension#261208Apollo
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States#272448ClinicalTrials.gov
• Carvedilol PAH A Pilot Study of Efficacy and Safety#290876ClinicalTrials.gov
• Sildenafil IV Bolus Study#329417ClinicalTrials.gov
• Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain#346818ClinicalTrials.gov
• Training With Whole Body Vibration Device in Patients With PAH#356577ClinicalTrials.gov
• Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension#391971HAL (France)
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure#623572ClinicalTrials.gov
• Artificial Intelligence in Pulmonary Hypertension: Current State and Future Prospects.#653336NCBI PubMed Central
• Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)#861326ClinicalTrials.gov
• Rivet PVS Therapy in Group 2 PH-HFpEF Canada#868413ClinicalTrials.gov
• Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide#909874ClinicalTrials.gov
• Lung Disease and FLNA Mutations#1008934ClinicalTrials.gov
• Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)#843787ClinicalTrials.gov
• Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study#471849HAL (France)
• The effects of chronic administration of Cannabidiol and Cannabidiol-Selexipag combination on haematological parameters, oxidative stress, BNP, and TNF-α in a rat model of Pulmonary Arterial Hypertension.#197568ResearchSpace
• Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)#474824ClinicalTrials.gov
• Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude#800926ClinicalTrials.gov
• Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution#136177ClinicalTrials.gov
• Biomarkers in Pediatric Congenital Heart Disease and PAH#184696ClinicalTrials.gov
• Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil#303624ClinicalTrials.gov
• Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.#458668NCBI PubMed Central
• Effect of Normatec Pump for Relief of Leg Edema#628624ClinicalTrials.gov
• Effect of Bosentan on Exercise Capacity at High Altitude#640472ClinicalTrials.gov
• 3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH#843044ClinicalTrials.gov
• Mobile Health Intervention to Improve Exercise in Pediatric PH#851910ClinicalTrials.gov
• Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism#852753ClinicalTrials.gov